JF
BCYC

Jump Financial’s Bicycle Therapeutics BCYC Stock Holding History

Jump Financial’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$244K Buy
52,544
+21,544
+69% +$123K ﹤0.01% 1577
2025
Q4 		$219K Buy
31,000
+9,579
+45% +$70.6K ﹤0.01% 1697
2025
Q3 		$166K Buy
21,421
+4,681
+28% +$35.3K ﹤0.01% 1655
2025
Q2 		$116K Buy
+16,740
New +$133K ﹤0.01% 1639
2024
Q4 		– Sell
-11,600
Closed -$263K – 1648
2024
Q3 		$263K Sell
11,600
-17,372
-60% -$401K 0.01% 1361
2024
Q2 		$586K Buy
+28,972
New +$655K 0.01% 1071
2024
Q1 		– Sell
-77,332
Closed -$1.4M – 1901
2023
Q4 		$1.4M Buy
77,332
+40,265
+109% +$666K 0.04% 538
2023
Q3 		$745K Buy
37,067
+18,906
+104% +$432K 0.03% 812
2023
Q2 		$463K Sell
18,161
-19,576
-52% -$455K 0.02% 1072
2023
Q1 		$803K Buy
37,737
+30,337
+410% +$761K 0.03% 692
2022
Q4 		$219K Buy
+7,400
New +$199K 0.01% 1238
2022
Q2 		– Sell
-28,176
Closed -$1.24M – 1619
2022
Q1 		$1.24M Sell
28,176
-3,031
-10% -$142K 0.05% 450
2021
Q4 		$1.9M Buy
31,207
+14,007
+81% +$773K 0.12% 221
2021
Q3 		$715K Buy
+17,200
New +$602K 0.05% 380

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jump Financial's BCYC Position: Q1 2026 in Review

Jump Financial increased its Bicycle Therapeutics (BCYC) stake by 69% in Q1 2026, buying an estimated $123K and bringing the position to 52,544 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Jump Financial first reported a position in BCYC in Q3 2021 and has held it in 14 quarters since. The position peaked at $1.9M in Q4 2021. 98 funds tracked by Wall St. Rank hold BCYC as of Q1 2026.

  • Jump Financial held 52,544 shares of Bicycle Therapeutics worth $244K as of Q1 2026.
  • Jump Financial bought 21,544 Bicycle Therapeutics shares in Q1 2026, an estimated $123K.
  • Bicycle Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q1 2026, its #1577 holding.
  • Jump Financial first reported a position in Bicycle Therapeutics in Q3 2021 and has held it in 14 quarters since.
  • Jump Financial's Bicycle Therapeutics position peaked at $1.9M in Q4 2021.
  • 98 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q1 2026.

Based on Jump Financial's 13F filing for Q1 2026, filed 14 May 2026.